Tokyo (Japan) and Munich/Martinsried (Germany), June, 2012 Arte Corporation and ProJect Pharmaceutics have been working closely on the development of a new type of dual chamber prefillable syringe for freeze-dried pharmaceuticals. The two companies have joined together with the objective to provide innovative dual chamber syringes for the global pharmaceutical market. This type of device,
Have you ever calculated the drawback on direct and opportunity costs when your freeze dryer is blocked by lyophilization cycles which take several days? Take this opportunity and have your cycle parameters checked for 2,000 € only. Just send us your lyophilization process parameters, a printout of an actual lyo run and some samples. Our
Budget is often scarce for pharmaceutical development projects before the drug has even shown proof of concept in first clinical trials. In that early stage, many drug developing companies are hesitant to spend the money for a fully-fledged pharmaceutical development of the formulation. Thus, quite often formulations in preclinical studies and clinical stages I and
ProJect Pharmaceutics introduces Predictive Formulation Analytics for a rational design of optimized biopharmaceutical formulations.
Munich/Martinsried, December, 2011 Protein drug formulation is particularly challenging due to structural complexity and instability. The biological activity of most recombinant proteins emanates specifically from their 3-dimensional structure which needs to remain unaltered throughout the shelf-life of the product. However, cleavage or aggregation incidents may not only reduce efficacy but also produce adverse immunologic effects.
Developing a new drug that addresses an unmet medical need is a challenging but rewarding objective in the life of a drug-development scientist. But even after a candidate has been identified and regulatory hurdles successfully cleared, there are always a set of new challenges that loom on a new drug’s path to commercial scale manufacturing.
Introducing an optimized process management concept from drug development to drug manufacturability: Advaceutics®
Reducing risk, defining time lines and increasing cost efficiency on a new drug’s way to commercial scale manufacturing. Munich/Martinsried, August 25, 2011 – ProJect Pharmaceutics (www.project-pharmaceutics.com) ProJect Pharmaceutics (PJP), who started operations last year, introduces its innovative approach Advaceutics ® to balance the know-how between formulation science, pharmaceutical process development and drug delivery technologies efficiently.